How could a gene that causes one type of ALS be switched off? In episode 87, Tim Miller from the Washington University in St. Louis discusses his research into therapies that target the single strands of DNA or RNA which cause many cases of amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig’s disease. His article “Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS” was published with multiple co-authors on July 9th 2020 in the New England Journal of Medicine

Silencing an ALS Gene - Tim Miller
Silencing an ALS Gene - Tim Miller
Silencing an ALS Gene - Tim MillerSilencing an ALS Gene - Tim Miller
{{svg_share_icon}}
Click bottom of waveform to add your comments


 

Websites and other resources

 

 
Select media and press
 

 

 

Bonus Clips

🔊 Access bonus content here.

Support us for as little as $1 per month at Patreon. Cancel anytime.

We’re not a registered tax-exempt organization, so unfortunately gifts aren’t tax deductible.

Hosts / Producers

Ryan Watkins &  Doug Leigh

How to Cite

Watkins, R., Leigh, D., & Miller, T.. (2020). Parsing Science – Silencing an ALS Gene. doi: 10.6084/m9.figshare.13232651

Music

What’s The Angle? by Shane Ivers

Transcript

Coming soon!


Share a clip from the episode